1-20 of 1047
Journal Articles
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
×Close Modal
Sort by
Journal Articles

The impact of response kinetics for multiple myeloma in the era of novel agents

Clinical Trials & Observations
Yuting Yan, Xuehan Mao, Jiahui Liu, Huishou Fan, Chenxing Du ...
Blood Advances (8 October 2019) 3 (19): 2895–2904.
DOI: https://doi.org/10.1182/bloodadvances.2019000432
Published: 2019
Includes: Supplemental data
Journal Articles

Moxetumomab pasudotox for hairy cell leukemia: preclinical development to FDA approval

Adam Yuh Lin, Shira Naomi Dinner
Blood Advances (8 October 2019) 3 (19): 2905–2910.
DOI: https://doi.org/10.1182/bloodadvances.2019000507
Published: 2019
Journal Articles

Butyrogenic bacteria after acute graft-versus-host disease (GVHD) are associated with the development of steroid-refractory GVHD

Jonathan L. Golob, Martha M. DeMeules, Tillie Loeffelholz, Z. Z. Quinn, Michael K. Dame ...
Blood Advances (4 October 2019) 3 (19): 2866–2869.
DOI: https://doi.org/10.1182/bloodadvances.2019000362
Published: 2019
Includes: Supplemental data
Journal Articles

Donor T-cell–derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract

Kate H. Gartlan, Motoko Koyama, Katie E. Lineburg, Karshing Chang, Kathleen S. Ensbey ...
Blood Advances (4 October 2019) 3 (19): 2859–2865.
DOI: https://doi.org/10.1182/bloodadvances.2019000053
Published: 2019
Includes: Supplemental data
Journal Articles

Identification of a tumor-specific allo-HLA–restricted γδTCR

G. J. J. Kierkels, W. Scheper, A. D. Meringa, I. Johanna, D. X. Beringer ...
Blood Advances (4 October 2019) 3 (19): 2870–2882.
DOI: https://doi.org/10.1182/bloodadvances.2019032409
Published: 2019
Includes: Supplemental data
Journal Articles

High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells

Hongjie Wang, Zhinan Liu, Chang Li, Sucheol Gil, Thalia Papayannopoulou ...
Blood Advances (4 October 2019) 3 (19): 2883–2894.
DOI: https://doi.org/10.1182/bloodadvances.2019000706
Published: 2019
Includes: Supplemental data
Journal Articles

High-efficiency CRISPR induction of t(9;11) chromosomal translocations and acute leukemias in human blood stem cells

Johan Jeong, Astraea Jager, Pablo Domizi, Mara Pavel-Dinu, Linda Gojenola ...
Blood Advances (3 October 2019) 3 (19): 2825–2835.
DOI: https://doi.org/10.1182/bloodadvances.2019000450
Published: 2019
Includes: Supplemental data
Journal Articles

DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes

Brian Reilly, Tiffany N. Tanaka, Dinh Diep, Huwate Yeerna, Pablo Tamayo ...
Blood Advances (3 October 2019) 3 (19): 2845–2858.
DOI: https://doi.org/10.1182/bloodadvances.2019000192
Published: 2019
Includes: Supplemental data
Journal Articles

Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancy

Scott R. Solomon, Andrew St. Martin, Nirav N. Shah, Giancarlo Fatobene, Monzr M. Al Malki ...
Blood Advances (3 October 2019) 3 (19): 2836–2844.
DOI: https://doi.org/10.1182/bloodadvances.2019000627
Published: 2019
Journal Articles

Reversal of a rheologic cardiomyopathy following hematopoietic stem cell transplantation for sickle cell disease

Vandana Sachdev, Matthew Hsieh, Neal Jeffries, Anna Noreuil, Wen Li ...
Blood Advances (2 October 2019) 3 (19): 2816–2824.
DOI: https://doi.org/10.1182/bloodadvances.2019000387
Published: 2019
Includes: Supplemental data
Journal Articles

T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma

Alfred L. Garfall, Ehren K. Dancy, Adam D. Cohen, Wei-Ting Hwang, Joseph A. Fraietta ...
Blood Advances (1 October 2019) 3 (19): 2812–2815.
DOI: https://doi.org/10.1182/bloodadvances.2019000600
Published: 2019
Includes: Supplemental data
Journal Articles

Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance

Joshua W. D. Tobin, Gabrielle Rule, Katherine Colvin, Lourdes Calvente, David Hodgson ...
Blood Advances (30 September 2019) 3 (19): 2804–2811.
DOI: https://doi.org/10.1182/bloodadvances.2019000458
Published: 2019
Includes: Supplemental data
Journal Articles

Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma

Brian C.-H. Chiu, Zhou Zhang, Qiancheng You, Chang Zeng, Elizabeth Stepniak ...
Blood Advances (30 September 2019) 3 (19): 2790–2799.
DOI: https://doi.org/10.1182/bloodadvances.2019000175
Published: 2019
Includes: Supplemental data
Journal Articles

CXCR4 S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia

Joshua N. Gustine, Lian Xu, Nicholas Tsakmaklis, Maria G. Demos, Amanda Kofides ...
Blood Advances (30 September 2019) 3 (19): 2800–2803.
DOI: https://doi.org/10.1182/bloodadvances.2019000635
Published: 2019
Includes: Supplemental data
Journal Articles

Heterogeneity in neutrophil responses to immune complexes

Madelaine Duarte, Maragatha Kuchibhatla, Sanjay Khandelwal, Gowthami M. Arepally, Grace M. Lee
Blood Advances (25 September 2019) 3 (19): 2778–2789.
DOI: https://doi.org/10.1182/bloodadvances.2019000235
Published: 2019
Includes: Supplemental data
Journal Articles

Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients

Yoshihiro Inamoto, Jennifer White, Reiko Ito, Paul J. Martin, Giancarlo Fatobene ...
Blood Advances (24 September 2019) 3 (18): 2764–2777.
DOI: https://doi.org/10.1182/bloodadvances.2019000386
Published: 2019
Journal Articles

Efficacy of emicizumab in a pediatric patient with type 3 von Willebrand disease and alloantibodies

Angela C. Weyand, Veronica H. Flood, Jordan A. Shavit, Steven W. Pipe
Blood Advances (20 September 2019) 3 (18): 2748–2750.
DOI: https://doi.org/10.1182/bloodadvances.2019000656
Published: 2019
Journal Articles

MMP9 inhibition increases erythropoiesis in RPS14-deficient del(5q) MDS models through suppression of TGF-β pathways

Minyoung Youn, Haigen Huang, Cheng Chen, Sharon Kam, Mark C. Wilkes ...
Blood Advances (20 September 2019) 3 (18): 2751–2763.
DOI: https://doi.org/10.1182/bloodadvances.2019000537
Published: 2019
Includes: Supplemental data
Journal Articles

Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years

Uma Borate, Brianna A. Norris, Abby Statler, Rongwei Fu, Taylor Bucy ...
Blood Advances (19 September 2019) 3 (18): 2738–2747.
DOI: https://doi.org/10.1182/bloodadvances.2019000293
Published: 2019
Journal Articles

Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation

Betty K. Hamilton, Lisa A. Rybicki, David Grove, Christina Ferraro, Jamie Starn ...
Blood Advances (17 September 2019) 3 (18): 2732–2737.
DOI: https://doi.org/10.1182/bloodadvances.2019000345
Published: 2019